![Vasily Andrianov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Vasily Andrianov worked as the VP-Clinical Development & Medical Affairs at Inhibrx, Inc. from 2021 to 2024.
He holds a doctorate degree from Pavlov First Saint Petersburg State Medical University.
Anciens postes connus de Vasily Andrianov
| Sociétés | Poste | Fin |
|---|---|---|
| INHIBRX, INC. | Directeur Technique/Scientifique/R&D | 30/05/2024 |
Formation de Vasily Andrianov
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Pavlov First Saint Petersburg State Medical University
 Pavlov First Saint Petersburg State Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibrx, Inc.
 Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
